Cuba’s National Clinical Trials Coordinating Center: Emergence, Evolution, and Main Results

Fuente: Redalyc
Enregistré dans:
Détails bibliographiques
Auteur principal: María A. Pascual
Format: Artículo científico
Langue:en
Publié: Medical Education Cooperation with Cuba 2011
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1876423441348820992
author María A. Pascual
author_facet María A. Pascual
contents Cuba’s National Clinical Trials Coordinating Center: Emergence, Evolution, and Main Results María A. Pascual Gladys Jiménez Ania Torres Martha M. Fors Isabel López Medicina Cuba drug industry clinical trial clinical evaluation Contract research organization The rapid development of Cuba’s pharmaceutical industry in the 1990s created a need for structures to ensure clinical evaluation of products before their introduction into medical practice and subsequent marketing. One of the centers founded for this purpose was the National Clinical Trials Coordinating Center. This paper summarizes the factors that motivated the creation of the Center and presents a brief history of its organizational develop- ment over the last 17 years. It also describes the main components of the system for designing and conducting clinical trials, and the most significant contributions of each toward achieving the Center’s objectives. 2011 artículo científico 1555-7960 https://www.redalyc.org/articulo.oa?id=437542077010 en http://www.redalyc.org/revista.oa?id=4375 MEDICC Review application/pdf Medical Education Cooperation with Cuba MEDICC Review (Estados Unidos de América) Num.1 Vol.13
format Artículo científico
id redalyc_437542077010
institution Redalyc
language en
publishDate 2011
publisher Medical Education Cooperation with Cuba
spellingShingle Cuba’s National Clinical Trials Coordinating Center: Emergence, Evolution, and Main Results
María A. Pascual
Medicina
Cuba
drug industry
clinical trial
clinical evaluation
Contract research organization
Cuba’s National Clinical Trials Coordinating Center: Emergence, Evolution, and Main Results María A. Pascual Gladys Jiménez Ania Torres Martha M. Fors Isabel López Medicina Cuba drug industry clinical trial clinical evaluation Contract research organization The rapid development of Cuba’s pharmaceutical industry in the 1990s created a need for structures to ensure clinical evaluation of products before their introduction into medical practice and subsequent marketing. One of the centers founded for this purpose was the National Clinical Trials Coordinating Center. This paper summarizes the factors that motivated the creation of the Center and presents a brief history of its organizational develop- ment over the last 17 years. It also describes the main components of the system for designing and conducting clinical trials, and the most significant contributions of each toward achieving the Center’s objectives. 2011 artículo científico 1555-7960 https://www.redalyc.org/articulo.oa?id=437542077010 en http://www.redalyc.org/revista.oa?id=4375 MEDICC Review application/pdf Medical Education Cooperation with Cuba MEDICC Review (Estados Unidos de América) Num.1 Vol.13
title Cuba’s National Clinical Trials Coordinating Center: Emergence, Evolution, and Main Results
topic Medicina
Cuba
drug industry
clinical trial
clinical evaluation
Contract research organization
url https://www.redalyc.org/articulo.oa?id=437542077010